Stock listing
Apimeds Pharmaceuticals Us, Inc.
Selected listing: APUS · AMEX · USD · US
Apimeds Pharmaceuticals Us, Inc. (NYSE American: APUS), Health Technology. Latest release Sep 14, 2026: D. Boral Capital Acted as Sole Bookrunner to Apimeds…
- Ticker
- NYSE American: APUS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NYSE American
- Currency
- USD
About Apimeds Pharmaceuticals Us, Inc.
Apimeds Pharmaceuticals Us, Inc. (ticker: APUS) is a public company operating in the American market. Investors can find relevant information about its operations and performance on its dedicated public company page.
Latest news from Apimeds Pharmaceuticals Us, Inc.
D. Boral Capital Acted as Sole Bookrunner to Apimeds Pharmaceuticals US, Inc. (NYSE:APUS) in connection with its $13.5 Million Initial Public Offering
September 13, 2026
MindWave Innovations Inc., a Wholly Owned Subsidiary of Apimeds Pharmaceuticals US, Inc., Announces MindChain: World's First Fully Insured Blockchain, Launching in October
July 28, 2026
Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program
May 5, 2026
Apimeds Pharmaceuticals US : Annual Report for Fiscal Year Ending December 31, 2025 (Form 10-K)
May 4, 2026
Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.
March 25, 2026
Research Apimeds Pharmaceuticals Us, Inc.
Apimeds Pharmaceuticals Us, Inc. company profile
View the public company page for Apimeds Pharmaceuticals Us, Inc. on 6ix.
Apimeds Pharmaceuticals Us, Inc. news
Read company news and market updates connected to Apimeds Pharmaceuticals Us, Inc..
Apimeds Pharmaceuticals Us, Inc. investor events
Find investor webinars, events, and replay context for Apimeds Pharmaceuticals Us, Inc..